Please use this identifier to cite or link to this item: https://ninho.inca.gov.br/jspui/handle/123456789/3571
Full metadata record
DC FieldValueLanguage
dc.contributor.authorInstituto Nacional de Câncer José Alencar Gomes da Silva-
dc.contributor.authorInstituto Nacional de Câncer (Brasil)-
dc.contributor.authorINCA-
dc.contributor.authorSistema Único de Saúde (Brasil)-
dc.contributor.authorBrasil. Ministério da Saúde-
dc.date.accessioned2021-08-03T15:50:50Z-
dc.date.available2021-08-03T15:50:50Z-
dc.date.issued2020-11-
dc.identifier.urihttp://sr-vmlxaph03:8080/jspui/handle/123456789/3571-
dc.description2 p.-
dc.language.isoPortpt_BR
dc.publisherINCApt_BR
dc.relation.ispartofseriesAno IV, n. 43.-
dc.subjectAdenocarcinomapt_BR
dc.subjectNeoplasias da Próstatapt_BR
dc.subjectProstatic Neoplasms-
dc.subjectNeoplasias de la Próstata-
dc.subjectTratamento Farmacológico-
dc.subjectDrug Therapy-
dc.subjectQuimioterapia-
dc.titleQuimioterapia para adenocarcinoma de próstata resistente à hormonioterapia em paciente orquiectomizadopt_BR
dc.TypeRevistas/Boletinspt_BR
Appears in Collections:Informe SUS - ONCO 2020

Files in This Item:
File Description SizeFormat 
informe-sus-onco-novembro2020.pdf444.83 kBAdobe PDFView/Open


Items in DSpace are protected by copyright, with all rights reserved, unless otherwise indicated.